Comparison of the live attenuated mumps vaccine (Miyahara strain) with its preattenuated parental strain
Journal Title: Journal of Vaccines & Immunization - Year 2013, Vol 1, Issue 2
Abstract
Live attenuated mumps vaccines have been developed by passaging the field isolates in cells that differ from the natural host. To study mumps viral (MuV) attenuation at the genomic level, we compared a live attenuated mumps vaccine (Miyahara strain) to its preattenuated parental strain. These two strains exhibited several phenotypic differences. The parental strain grew faster, reached a higher titer, and formed larger plaques and syncytia in Vero cells compared to the vaccine strain. In addition, intracranial injection of parental strain in neonatal rats resulted in greater ventricular enlargement than that caused by the vaccine strain. Four nucleotide changes leading to amino acid substitutions were found between the two viral genomes. One change is present in the N and L genes, respectively, and two in the F gene. The fusogenic activity of the cloned parental F gene evaluated by a cell-cell fusion assay was weaker than that of the vaccine F gene, and did not correspond to the activity caused by the living parental and vaccine strains. The transcriptional activities of N and L proteins were monitored by a CAT minigenome assay. Cloned parental N gene produced almost the same CAT activity as vaccine N, and cloned parental L gene produced significantly higher CAT activity than vaccine L. Thus among four nucleotide changes, the three occurring in N and F were not found to relate to the viral outcome, but we confirmed that at least one change in the L protein was involved in the growth phenotype of parental MuV.
Authors and Affiliations
Nagata S, Maedera T, Kidokoro M, Takeuchi K, Kuranaga M, Takedaa M, Kato A
Keywords
Related Articles
- EP ID EP567007
- DOI 10.14312/2053-1273.2013-3
- Views 61
- Downloads 0
Comparison of the live attenuated mumps vaccine (Miyahara strain) with its preattenuated parental strain
Live attenuated mumps vaccines have been developed by passaging the field isolates in cells that differ from the natural host. To study mumps viral (MuV) attenuation at the genomic level, we compared a live attenuated mu...
Routine immunization services in Africa: back to basics
National immunization programmes were created as a sequel to smallpox eradication when countries undertook mass immunization campaigns and other control measures to fight the disease. As smallpox came near to eradication...
An evaluation of the indirect cohort method to estimate the effectiveness of the pneumococcal polysaccharide vaccine
We examined the validity of the indirect cohort method as a rapid assessment tool to estimate pneumococcal polysaccharide vaccine effectiveness (VE). Using evidence from published clinical trials, we reviewed the primary...
Hospital epidemiology and costs of pertussis in France: A retrospective database analysis
Background: Pertussis vaccination coverage remains unsatisfactory in adults in France and pertussis is the leading cause of death due to bacterial infection in infants up to 3 months of age, whom are most often infected...
From package to protection: how do we close global coverage gaps to optimize the impact of vaccination?
The success of every vaccination program is dependent upon reaching and sustaining the target coverage rates. Vaccination programs are currently facing coverage gaps where target coverages are never reached and may also...